{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:47:56Z","timestamp":1774374476141,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nmd.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T17:35:05Z","timestamp":1498066505000},"page":"816-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis"],"prefix":"10.1016","volume":"27","author":[{"given":"Melissa","family":"Nel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahjoubeh","family":"Jalali Sefid Dashti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junaid","family":"Gamieldien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine M.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2017.06.009_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/mus.24348","article-title":"Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa","volume":"51","author":"Mombaur","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2017.06.009_bib0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.nmd.2007.07.002","article-title":"Myasthenia gravis in South Africans: racial differences in clinical manifestations","volume":"17","author":"Heckmann","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.06.009_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7196\/SAMJ.5390","article-title":"The characteristics of juvenile myasthenia gravis among South Africans","volume":"102","author":"Heckmann","year":"2012","journal-title":"S Afr Med J"},{"key":"10.1016\/j.nmd.2017.06.009_bib0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/mus.25154","article-title":"Characteristics of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort","volume":"54","author":"Huda","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2017.06.009_bib0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/jhg.2015.146","article-title":"The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis","volume":"61","author":"Nel","year":"2016","journal-title":"J Hum Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gene.2009.61","article-title":"A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis","volume":"11","author":"Heckmann","year":"2010","journal-title":"Genes Immun"},{"key":"10.1016\/j.nmd.2017.06.009_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nmd.2014.02.010","article-title":"The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis","volume":"24","author":"Auret","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.06.009_bib0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/gepi.20572","article-title":"Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants","volume":"35","author":"Guey","year":"2011","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.nmd.2017.06.009_bib0050","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nature07811","article-title":"Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease","volume":"458","author":"Gu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2017.06.009_bib0055","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1212\/NXG.0000000000000093","article-title":"A new dawn for genetic association studies in multiple sclerosis","volume":"2","author":"Kantarci","year":"2016","journal-title":"Neurol Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.06.009_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7196\/SAMJ.4860","article-title":"Launch of the Southern African human genome programme","volume":"101","author":"Pepper","year":"2011","journal-title":"S Afr Med J"},{"key":"10.1016\/j.nmd.2017.06.009_bib0070","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0075","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0080","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0090","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/bioinformatics\/btq427","article-title":"A fast and robust statistical test based on likelihood ratio with Bartlett correction to identify Granger causality between gene sets","volume":"26","author":"Fujita","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nmd.2017.06.009_bib0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.nmd.2017.06.009_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.06.009_bib0105","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","article-title":"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tig.2010.07.004","article-title":"Towards a complete resolution of the genetic architecture of disease","volume":"26","author":"Singleton","year":"2010","journal-title":"Trends Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/1471-2164-14-644","article-title":"Genetic diversity in black South Africans from Soweto","volume":"14","author":"May","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.nmd.2017.06.009_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature13997","article-title":"The African Genome variation project shapes medical genetics in Africa","volume":"517","author":"Gurdasani","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2017.06.009_bib0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/physiolgenomics.00158.2004","article-title":"Definition of the unique human extraocular muscle allotype by expression profiling","volume":"22","author":"Fischer","year":"2005","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.nmd.2017.06.009_bib0130","doi-asserted-by":"crossref","first-page":"19820","DOI":"10.1038\/srep19820","article-title":"Semantic interrogation of a multi knowledge domain ontological model of tendinopathy identifies four strong candidate risk genes","volume":"6","author":"Saunders","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2017.06.009_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","article-title":"IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis","volume":"3","author":"Maurer","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nmd.2017.06.009_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091927","article-title":"Analysis of serum miRNA profiles of myasthenia gravis patients","volume":"9","author":"Nogales-Gadea","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.06.009_bib0145","doi-asserted-by":"crossref","first-page":"724715","DOI":"10.1155\/2015\/724715","article-title":"Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis","volume":"2015","author":"Cao","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nmd.2017.06.009_bib0150","doi-asserted-by":"crossref","first-page":"518942","DOI":"10.1155\/2014\/518942","article-title":"Clinical study of effects of Jian Ji Ning, a Chinese herbal medicine compound preparation, in treating patients with myasthenia gravis via the regulation of differential MicroRNAs expression in serum","volume":"2014","author":"Jiang","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.nmd.2017.06.009_bib0155","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1167\/iovs.14-14422","article-title":"RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment","volume":"55","author":"Zhou","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Database issue","key":"10.1016\/j.nmd.2017.06.009_bib0160","doi-asserted-by":"crossref","first-page":"D86","DOI":"10.1093\/nar\/gkt1028","article-title":"PolymiRTS database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways","volume":"42","author":"Bhattacharya","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2105-15-73","article-title":"mrSNP: software to detect SNP effects on microRNA binding","volume":"15","author":"Deveci","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.nmd.2017.06.009_bib0170","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ng2135","article-title":"The role of site accessibility in microRNA target recognition","volume":"39","author":"Kertesz","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0175","doi-asserted-by":"crossref","first-page":"bav029","DOI":"10.1093\/database\/bav029","article-title":"An update of miRNASNP database for better SNP selection by GWAS data, miRNA expression and online tools","volume":"2015","author":"Gong","year":"2015","journal-title":"Database (Oxford)"},{"issue":"Web Server issue","key":"10.1016\/j.nmd.2017.06.009_bib0180","doi-asserted-by":"crossref","first-page":"W361","DOI":"10.1093\/nar\/gku406","article-title":"RBPmap: a web server for mapping binding sites of RNA-binding proteins","volume":"42","author":"Paz","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0185","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/bioinformatics\/btv009","article-title":"An integrative approach to predicting the functional effects of non-coding and coding sequence variation","volume":"31","author":"Shihab","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nmd.2017.06.009_bib0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","article-title":"PROMO: detection of known transcription regulatory elements using species-tailored searches","volume":"18","author":"Messeguer","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nmd.2017.06.009_bib0195","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/nar\/gkg605","article-title":"Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN","volume":"31","author":"Farre","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/nar\/24.1.238","article-title":"TRANSFAC: a database on transcription factors and their DNA binding sites","volume":"24","author":"Wingender","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.06.009_bib0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajhg.2010.02.014","article-title":"Strong maternal Khoisan contribution to the South African coloured population: a case of gender-biased admixture","volume":"86","author":"Quintana-Murci","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2017.06.009_bib0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/humu.20023","article-title":"DNA analysis by MALDI-TOF mass spectrometry","volume":"23","author":"Gut","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.06.009_bib0215","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/art.37913","article-title":"Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic loci","volume":"65","author":"Prahalad","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nmd.2017.06.009_bib0220","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/ard.2009.120170","article-title":"Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk","volume":"69","author":"Karlson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2017.06.009_bib0225","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/srep04904","article-title":"Cumulative effects of variants identified by genome-wide association studies in IgA nephropathy","volume":"4","author":"Zhou","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2017.06.009_bib0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/annrheumdis-2013-204133","article-title":"A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk","volume":"74","author":"Yarwood","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2017.06.009_bib0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00424-011-0925-6","article-title":"How to make rapid eye movements \u201crapid\u201d: the role of growth factors for muscle contractile properties","volume":"461","author":"Li","year":"2011","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.nmd.2017.06.009_bib0240","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1167\/iovs.08-3333","article-title":"Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles","volume":"50","author":"Liu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nmd.2017.06.009_bib0245","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1196\/annals.1405.037","article-title":"Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?","volume":"1132","author":"Soltys","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2017.06.009_bib0250","doi-asserted-by":"crossref","first-page":"25960","DOI":"10.1038\/srep25960","article-title":"Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS","volume":"6","author":"Allodi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2017.06.009_bib0255","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2017.06.009_bib0260","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A genome-wide association study of myasthenia gravis","volume":"72","author":"Renton","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2017.06.009_bib0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2011.06123.x","article-title":"Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles","volume":"1233","author":"Serra","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2017.06.009_bib0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13395-014-0028-0","article-title":"A role for Galgt1 in skeletal muscle regeneration","volume":"5","author":"Singhal","year":"2015","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.nmd.2017.06.009_bib0275","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.abb.2015.02.007","article-title":"Regulatory function of glycosphingolipids in the inflammation and degeneration","volume":"571","author":"Furukawa","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nmd.2017.06.009_bib0280","doi-asserted-by":"crossref","first-page":"22405","DOI":"10.1073\/pnas.0912336106","article-title":"Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues","volume":"106","author":"Ohmi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2017.06.009_bib0285","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bbamem.2007.10.019","article-title":"Ceramides modulate cell-surface acetylcholine receptor levels","volume":"1778","author":"Gallegos","year":"2008","journal-title":"Biochim Biophys Acta"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617303620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617303620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:05:57Z","timestamp":1760774757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896617303620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0960896617303620"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2017.06.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}